- Market Radar
- /
- INKT
Sagehood
Financial Analyst
PREMIUM
Technical Trader
PREMIUM
Valuation Projection
PREMIUM
Social Media Buzz
PREMIUM
News Agent
PREMIUM
Macro Economist
PREMIUM
About INKT
7/7/2025
Comprehensive Analysis
Financial Health
- Balance Sheet Weakness: MiNK Therapeutics (INKT) has negative equity (-$21.8M) and a debt-to-asset ratio >1, signaling severe financial distress. Current ratio of 0.30 and cash reserves of $3.2M highlight liquidity risks.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
- View 5 tickers daily
- Create and manage Watchlists
- Import portfolios (no personalized insights)
- Chat with the general Sagehood AI Agent
- Market Radar: Preview access only
Premium Membership
- Unlimited AI-generated insights across all sections
- Market Overview
- Market Radar (AI-driven investment opportunities)
- Access to all Sagehood AI agents, including domain-specific experts
- Personalized insights and actionable recommendations for smarter investing